JNJ
JOHNSON & JOHNSON
NYSE: JNJ · New Brunswick, NJ · Healthcare
$263.81-3.80 (-1.42%)Closed
Market Cap$635.07B
Cash$17.23Bmost recent
Runwayprofitable
P/E (TTM)23.9EPS $11.03
52-Wk Range$181.90 – $278.43
Avg Volume8.1M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$263.81+70.1%
Pipeline

Drug candidates sponsored by JOHNSON & JOHNSON · ClinicalTrials.gov

89 drugs · 100 trials
PhaseDrug / CandidateIndicationsStatusNext CompletionTrials
Phase 4Cetirizine
Allergic Rhinitis+3 more
Completed
2001-07past
1
Phase 4loperamide-simethicone
Diarrhea
Completed
2008-10past
1
Phase 4placebo
Pain+4 more
Completed
2011-06-24past
2
Phase 4Risperidone
Schizophrenia+3 more
Completed
2011-07past
1
Phase 4Unnamed
Healthy
Completed
2021-02-01past
1
Phase 4Golimumab
Spondylitis, Ankylosing+1 more
Completed
2021-11-15past
1
Phase 4Ibrutinib 420 mg
Leukemia, Lymphocytic, Chronic, B-Cell+1 more
Completed
2023-05-03past
1
Phase 4tramadol hydrochloride + acetaminophen
Surgery, Oral+1 more
Completed—1
Phase 4risperidone, quetiapine
Schizophrenia+1 more
Completed—1
Phase 4Quetiapine
PTSD
Completed—1
Phase 3Pegylated liposomal doxorubicin
Metastatic Breast Cancer
Terminated
2005-12past
1
Phase 3CG5503 IR;tapentadol
Arthralgia+4 more
Completed
2007-05past
1
Phase 3CG5503
Diabetic Neuropathy
Completed
2008-08past
1
Phase 3Unnamed
Breast Cancer
Terminated
2009-10past
1
Phase 35% Minoxidil Topical Foam
Androgenetic Alopecia
Completed
2011-08past
1
Phase 3Ondansetron 4 ug/kg b.i.d. + Cognitive Behavioral Therapy
Alcoholism
Completed
2012-12past
1
Phase 3topiramate
Epilepsy+5 more
Completed—6
Phase 3galantamine
Dementia, Vascular
Completed—1
Phase 3galantamine ER
Alzheimer's Disease
Completed—1
Phase 3doripenem
Urinary Tract Infections+6 more
Completed—3
Phase 3Paliperidone ER
Affective Psychosis, Bipolar+3 more
Completed—3
Phase 3Levofloxacin
Urinary Tract Infections+3 more
Completed—1
Phase 3levofloxacin, azithromycin, amoxicillin/clavulanate
Bronchitis+1 more
Completed—1
Phase 3acetaminophen
Osteoarthritis, Hip+1 more
Completed—1
Phase 2Yondelis
Liposarcoma+1 more
Completed
2008-05past
1
Phase 2ACALABRUTINIB
Refractory Aggressive B-cell Lymphomas+12 more
Active, not recruiting
2024-11-23past
1
Phase 2epoetin alfa
Anemia+1 more
Completed—2
Phase 2R092670
Schizophrenia
Completed—1
Phase 1Simvastatin
Healthy
Completed
2008-09past
1
Phase 1Canagliflozin (JNJ-28431754)
Renal Insufficiency+1 more
Completed
2008-11past
1
Phase 1divalproex sodium ER/paliperidone ER
Schizophrenia+2 more
Completed
2009-04past
1
Phase 1Unnamed
Vision Disorders
Completed
2016-06past
1
Phase 1Unnamed
Gingivitis+1 more
Completed
2019-12-19past
1
Phase 1Study Cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5)
Acne Vulgaris
Completed
2021-09-13past
1
Phase 1Acetaminophen/Naproxen Sodium
Orthodontic Pain
Completed
2024-02-12past
1
Phase 1JNJ-90301900
Squamous Cell Carcinoma of Head and Neck
Recruiting
2028-07-14
1
Phase 1paliperidone ER; Carbamazepine
Schizophrenia+1 more
Completed—1
Phase 1Canagliflozin/Metformin
Healthy
Completed—1
Phase 1Drug combination/ 26489112
Healthy
Completed—1
Phase 1JNJ-41443532
Healthy
Completed—1
Phase 1JNJ-39439335, Placebo
Pain
Completed—1
Phase 1Canagliflozin
Healthy
Completed—1
Phase 1Topiramate oral liquid formulation;Topiramate Sprinkle formulation
Epilepsy
Completed—1
N/AUnnamed
Pain
Completed
2008-01past
1
N/AUnnamed
Astigmatism
Completed
2008-01past
1
N/AUnnamed
Healthy
Completed
2008-09past
1
N/AUnnamed
Mineral Absorption in the Urine
Completed
2008-09past
1
N/AUnnamed
Myopia
Completed
2009-01past
1
N/AUnnamed
Atopic Dermatitis
Completed
2009-06past
1
N/AUnnamed
Refractive Error+1 more
Completed
2009-12-01past
1
N/AUnnamed
Myopia
Completed
2010-04-01past
1
N/AUnnamed
Myopia
Completed
2010-08-01past
1
N/AUnnamed
Blister
Completed
2010-11past
1
N/AUnnamed
Myopia
Completed
2011-10past
1
N/AUnnamed
Refractive Ametropia
Completed
2012-02past
1
N/AUnnamed
Astigmatism+1 more
Completed
2012-04past
1
N/AUnnamed
Presbyopia
Completed
2013-02past
1
N/AUnnamed
Measurement of Docosahexaenoic Acid Levels in Pre-school Children
Terminated
2014-03past
1
N/AUnnamed
Dentin Sensitivity
Completed
2014-05past
1
N/AUnnamed
Visual Correction
Completed
2014-06-25past
1
N/AUnnamed
Visual Acuity
Completed
2015-04past
1
N/AUnnamed
Visual Acuity
Completed
2016-06-01past
1
N/AUnnamed
Child Nutrition Sciences
Completed
2016-12-23past
1
N/AUnnamed
Stress
Completed
2017-12-31past
1
N/AIbrutinib
Leukemia, Lymphocytic, Chronic, B-Cell+1 more
Completed
2019-05-14past
1
N/ACanagliflozin 300 mg
Diabetes Mellitus, Type 2
Completed
2019-07-01past
1
N/AUnnamed
Visual Acuity
Completed
2020-03-28past
1
N/AUnnamed
Cataract+1 more
Completed
2020-09-11past
1
N/AUnnamed
Visual Acuity
Completed
2020-09-15past
1
N/AUnnamed
Visual Acuity
Completed
2020-09-29past
1
N/AAntibiotic Ointment
Wound Healing
Completed
2021-10-06past
1
N/AUnnamed
Visual Acuity
Completed
2021-10-29past
1
N/AUnnamed
Visual Acuity
Completed
2021-11-29past
1
N/AUnnamed
Visual Acuity
Completed
2022-01-13past
1
N/AUnnamed
Visual Acuity
Completed
2022-07-05past
1
N/AUnnamed
Refractive Error
Completed
2022-08-09past
1
N/AUnnamed
Growth
Completed
2022-10-11past
1
N/AUnnamed
Visual Acuity
Completed
2022-12-08past
1
N/AUnnamed
Refractive Error
Completed
2024-02-05past
1
N/AUnnamed
Visual Acuity
Completed
2024-06-24past
1
N/AUnnamed
Congenital Diaphragmatic Hernia
Active, not recruiting
2024-12-20past
1
N/AUnnamed
Refractive Error+3 more
Completed
2025-05-31past
1
N/AUnnamed
Cataracts
Completed
2025-06-30past
1
N/AUnnamed
Infant Formula
Completed
2025-10-31past
1
N/AUnnamed
Atrial Fibrillation
Not yet recruiting
2028-07-28
1
N/AUnnamed
Healthy
Completed—1
N/AAbiraterone Acetate
Prostate Neoplasms+3 more
Approved For Marketing—1
N/AUnnamed
Pure Red-cell Aplasia
Completed—1
N/AUnnamed
Female Contraception
Completed—1
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for JNJ. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.